{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:49:43Z","timestamp":1793656183786,"version":"4.5.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ZIAES103385"],"award-info":[{"award-number":["ZIAES103385"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"publisher","award":["W81XWH20C0031"],"award-info":[{"award-number":["W81XWH20C0031"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"publisher","award":["W81XWH20C0031"],"award-info":[{"award-number":["W81XWH20C0031"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20731-1","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:32:45Z","timestamp":1761125565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Fenofibrate differentially activates PPAR\u03b1-mediated lipid metabolism in rat kidney and liver"],"prefix":"10.1038","volume":"15","author":[{"given":"Venkat R.","family":"Pannala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele R.","family":"Balik-Meisner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Mav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiral P.","family":"Phadke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth H.","family":"Scholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchir R.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott S.","family":"Auerbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Wallqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20731_CR1","doi-asserted-by":"publisher","first-page":"a040576","DOI":"10.1101\/cshperspect.a040576","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel, N. S. Lipid metabolism. Cold Spring Harb Perspect. Biol. 13, a040576. https:\/\/doi.org\/10.1101\/cshperspect.a040576 (2021).","journal-title":"Cold Spring Harb Perspect. Biol."},{"key":"20731_CR2","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00018-018-2765-4","volume":"75","author":"AL Santos","year":"2018","unstructured":"Santos, A. L. & Preta, G. Lipids in the cell: organisation regulates function. Cell. Mol. Life Sci. 75, 1909\u20131927. https:\/\/doi.org\/10.1007\/s00018-018-2765-4 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"20731_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00041433-200306000-00008","volume":"14","author":"JE Schaffer","year":"2003","unstructured":"Schaffer, J. E. Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14, 281\u2013287. https:\/\/doi.org\/10.1097\/00041433-200306000-00008 (2003).","journal-title":"Curr. Opin. Lipidol."},{"key":"20731_CR4","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cmet.2012.04.006","volume":"15","author":"IJ Goldberg","year":"2012","unstructured":"Goldberg, I. J., Trent, C. M. & Schulze, P. C. Lipid metabolism and toxicity in the heart. Cell. Metab. 15, 805\u2013812. https:\/\/doi.org\/10.1016\/j.cmet.2012.04.006 (2012).","journal-title":"Cell. Metab."},{"key":"20731_CR5","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/sj.ki.5001834","volume":"70","author":"JM Weinberg","year":"2006","unstructured":"Weinberg, J. M. & Lipotoxicity Kidney Int. 70, 1560\u20131566, doi:https:\/\/doi.org\/10.1038\/sj.ki.5001834 (2006).","journal-title":"Kidney Int."},{"key":"20731_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.molmet.2018.07.006","volume":"16","author":"L Monteillet","year":"2018","unstructured":"Monteillet, L. et al. Intracellular lipids are an independent cause of liver injury and chronic kidney disease in non alcoholic fatty liver disease-like context. Mol. Metab. 16, 100\u2013115. https:\/\/doi.org\/10.1016\/j.molmet.2018.07.006 (2018).","journal-title":"Mol. Metab."},{"key":"20731_CR7","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen, D. H., Lykkesfeldt, J. & Tveden-Nyborg, P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell. Mol. Life Sci. 75, 3313\u20133327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6 (2018).","journal-title":"Cell. Mol. Life Sci."},{"key":"20731_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H. & Moshage, H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol. Int. 15, 21\u201335. https:\/\/doi.org\/10.1007\/s12072-020-10121-2 (2021).","journal-title":"Hepatol. Int."},{"key":"20731_CR9","doi-asserted-by":"publisher","first-page":"118615","DOI":"10.1016\/j.atherosclerosis.2024.118615","volume":"398","author":"E Giardini","year":"2024","unstructured":"Giardini, E., Moore, D., Sadlier, D., Godson, C. & Brennan, E. The dual role of lipids in chronic kidney disease: pathogenic culprits and therapeutic allies. Atherosclerosis 398, 118615. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2024.118615 (2024).","journal-title":"Atherosclerosis"},{"key":"20731_CR10","doi-asserted-by":"publisher","first-page":"722","DOI":"10.3390\/nu11040722","volume":"11","author":"Z Gai","year":"2019","unstructured":"Gai, Z. et al. Lipid accumulation and chronic kidney disease. Nutrients 11, 722. https:\/\/doi.org\/10.3390\/nu11040722 (2019).","journal-title":"Nutrients"},{"key":"20731_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrneph.2017.175","volume":"14","author":"S Agrawal","year":"2017","unstructured":"Agrawal, S., Zaritsky, J. J., Fornoni, A. & Smoyer, W. E. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat. Rev. Nephrol. 14, 70. https:\/\/doi.org\/10.1038\/nrneph.2017.175 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"20731_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-2275(20)30159-0","volume":"43","author":"R Walczak","year":"2002","unstructured":"Walczak, R. & Tontonoz, P. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J. Lipid Res. 43, 177\u2013186 (2002).","journal-title":"J. Lipid Res."},{"key":"20731_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.bbadis.2011.02.014","volume":"1812","author":"T Varga","year":"2011","unstructured":"Varga, T., Czimmerer, Z. & Nagy, L. PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation. Biochim. Biophys. Acta. 1812, 1007\u20131022. https:\/\/doi.org\/10.1016\/j.bbadis.2011.02.014 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"20731_CR14","doi-asserted-by":"publisher","first-page":"6321","DOI":"10.1021\/cr2001355","volume":"111","author":"GS Harmon","year":"2011","unstructured":"Harmon, G. S., Lam, M. T. & Glass, C. K. PPARs and lipid ligands in inflammation and metabolism. Chem. Rev. 111, 6321\u20136340. https:\/\/doi.org\/10.1021\/cr2001355 (2011).","journal-title":"Chem. Rev."},{"issue":"Suppl 3","key":"20731_CR15","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1038\/sj.ijo.0802499","volume":"27","author":"G Chinetti","year":"2003","unstructured":"Chinetti, G., Fruchart, J. C. & Staels, B. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl 3), S41\u2013S45. https:\/\/doi.org\/10.1038\/sj.ijo.0802499 (2003).","journal-title":"Int. J. Obes. Relat. Metab. Disord"},{"key":"20731_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2006.06.049","volume":"126","author":"AL Bookout","year":"2006","unstructured":"Bookout, A. L. et al. Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126, 789\u2013799. https:\/\/doi.org\/10.1016\/j.cell.2006.06.049 (2006).","journal-title":"Cell"},{"key":"20731_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.plipres.2005.12.002","volume":"45","author":"JN Feige","year":"2006","unstructured":"Feige, J. N., Gelman, L., Michalik, L., Desvergne, B. & Wahli, W. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Prog Lipid Res. 45, 120\u2013159. https:\/\/doi.org\/10.1016\/j.plipres.2005.12.002 (2006).","journal-title":"Prog Lipid Res."},{"key":"20731_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.biochi.2016.12.019","volume":"136","author":"S Kersten","year":"2017","unstructured":"Kersten, S. & Stienstra, R. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver. Biochimie 136, 75\u201384. https:\/\/doi.org\/10.1016\/j.biochi.2016.12.019 (2017).","journal-title":"Biochimie"},{"key":"20731_CR19","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1210\/er.2018-00064","volume":"39","author":"N Bougarne","year":"2018","unstructured":"Bougarne, N. et al. Molecular actions of PPARalpha in lipid metabolism and inflammation. Endocr. Rev. 39, 760\u2013802. https:\/\/doi.org\/10.1210\/er.2018-00064 (2018).","journal-title":"Endocr. Rev."},{"key":"20731_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2002.tb04258.x","volume":"967","author":"V Bocher","year":"2002","unstructured":"Bocher, V., Pineda-Torra, I., Fruchart, J. C. & Staels, B. PPARs: transcription factors controlling lipid and lipoprotein metabolism. Ann. Acad. Sci. 967, 7\u201318. https:\/\/doi.org\/10.1111\/j.1749-6632.2002.tb04258.x (2002).","journal-title":"Ann. Acad. Sci."},{"key":"20731_CR21","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","volume":"37","author":"K Schoonjans","year":"1996","unstructured":"Schoonjans, K., Staels, B. & Auwerx, J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 37, 907\u2013925 (1996).","journal-title":"J. Lipid Res."},{"key":"20731_CR22","doi-asserted-by":"publisher","first-page":"18667","DOI":"10.1074\/jbc.M412062200","volume":"280","author":"HA Hostetler","year":"2005","unstructured":"Hostetler, H. A., Petrescu, A. D., Kier, A. B. & Schroeder, F. Peroxisome proliferator-activated receptor alpha interacts with high affinity and is conformationally responsive to endogenous ligands. J. Biol. Chem. 280, 18667\u201318682. https:\/\/doi.org\/10.1074\/jbc.M412062200 (2005).","journal-title":"J. Biol. Chem."},{"key":"20731_CR23","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","volume":"94","author":"BM Forman","year":"1997","unstructured":"Forman, B. M., Chen, J. & Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc. Natl. Acad. Sci. USA. 94, 4312\u20134317. https:\/\/doi.org\/10.1073\/pnas.94.9.4312 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"20731_CR24","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/jm990554g","volume":"43","author":"TM Willson","year":"2000","unstructured":"Willson, T. M., Brown, P. J., Sternbach, D. D. & Henke, B. R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43, 527\u2013550. https:\/\/doi.org\/10.1021\/jm990554g (2000).","journal-title":"J. Med. Chem."},{"key":"20731_CR25","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1161\/ATVBAHA.108.179689","volume":"30","author":"F Lalloyer","year":"2010","unstructured":"Lalloyer, F. & Staels, B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc Biol. 30, 894\u2013899. https:\/\/doi.org\/10.1161\/ATVBAHA.108.179689 (2010).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"20731_CR26","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/meta.2001.21028","volume":"50","author":"A Taniguchi","year":"2001","unstructured":"Taniguchi, A. et al. Effects of bezafibrate on insulin sensitivity and insulin secretion in non-obese Japanese type 2 diabetic patients. Metabolism 50, 477\u2013480. https:\/\/doi.org\/10.1053\/meta.2001.21028 (2001).","journal-title":"Metabolism"},{"key":"20731_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11883-022-01028-4","volume":"24","author":"A Martin","year":"2022","unstructured":"Martin, A. et al. Management of dyslipidemia in patients with non-alcoholic fatty liver disease. Curr. Atheroscler Rep. 24, 533\u2013546. https:\/\/doi.org\/10.1007\/s11883-022-01028-4 (2022).","journal-title":"Curr. Atheroscler Rep."},{"key":"20731_CR28","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1161\/01.cir.98.19.2088","volume":"98","author":"B Staels","year":"1998","unstructured":"Staels, B. et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98, 2088\u20132093. https:\/\/doi.org\/10.1161\/01.cir.98.19.2088 (1998).","journal-title":"Circulation"},{"key":"20731_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TM Davis","year":"2011","unstructured":"Davis, T. M. et al. Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 54, 280\u2013290. https:\/\/doi.org\/10.1007\/s00125-010-1951-1 (2011).","journal-title":"Diabetologia"},{"key":"20731_CR30","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/eci.12068","volume":"43","author":"MS Kostapanos","year":"2013","unstructured":"Kostapanos, M. S., Florentin, M. & Elisaf, M. S. Fenofibrate and the kidney: an overview. Eur. J. Clin. Invest. 43, 522\u2013531. https:\/\/doi.org\/10.1111\/eci.12068 (2013).","journal-title":"Eur. J. Clin. Invest."},{"key":"20731_CR31","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.2165\/11208090-000000000-00000","volume":"71","author":"K McKeage","year":"2011","unstructured":"McKeage, K. & Keating, G. M. Fenofibrate: a review of its use in dyslipidaemia. Drugs 71, 1917\u20131946. https:\/\/doi.org\/10.2165\/11208090-000000000-00000 (2011).","journal-title":"Drugs"},{"key":"20731_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida, Y. & Yoneda, M. Current and future pharmacological therapies for NAFLD\/NASH. J. Gastroenterol. 53, 362\u2013376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1 (2018).","journal-title":"J. Gastroenterol."},{"key":"20731_CR33","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.drudis.2022.05.007","volume":"27","author":"A Mahmoudi","year":"2022","unstructured":"Mahmoudi, A., Jamialahmadi, T., Johnston, T. P. & Sahebkar, A. Impact of fenofibrate on NAFLD\/NASH: a genetic perspective. Drug Discov Today. 27, 2363\u20132372. https:\/\/doi.org\/10.1016\/j.drudis.2022.05.007 (2022).","journal-title":"Drug Discov Today"},{"key":"20731_CR34","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1586\/14779072.6.10.1319","volume":"6","author":"RS Rosenson","year":"2008","unstructured":"Rosenson, R. S. Fenofibrate: treatment of hyperlipidemia and beyond. Expert Rev. Cardiovasc. Ther. 6, 1319\u20131330. https:\/\/doi.org\/10.1586\/14779072.6.10.1319 (2008).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"20731_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.4082\/kjfm.2017.38.4.192","volume":"38","author":"S Kim","year":"2017","unstructured":"Kim, S., Ko, K., Park, S., Lee, D. R. & Lee, J. Effect of fenofibrate medication on renal function. Korean J. Fam Med. 38, 192\u2013198. https:\/\/doi.org\/10.4082\/kjfm.2017.38.4.192 (2017).","journal-title":"Korean J. Fam Med."},{"key":"20731_CR36","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1159\/000522081","volume":"47","author":"CF Hernandez-Arroyo","year":"2022","unstructured":"Hernandez-Arroyo, C. F., Kanduri, S. R., Justiniano, R., Martinez-Pitre, P. J. & Velez, J. C. Q. Improvement in kidney function after discontinuation of fenofibrate in outpatient nephrology consultation for chronic kidney disease. Kidney Blood Press. Res. 47, 586\u2013591. https:\/\/doi.org\/10.1159\/000522081 (2022).","journal-title":"Kidney Blood Press. Res."},{"key":"20731_CR37","first-page":"525","volume":"22","author":"N Ganne-Carrie","year":"1998","unstructured":"Ganne-Carrie, N. et al. Autoimmune hepatitis induced by fibrates. Gastroenterol. Clin. Biol. 22, 525\u2013529 (1998).","journal-title":"Gastroenterol. Clin. Biol."},{"key":"20731_CR38","first-page":"245","volume":"67","author":"CY Ho","year":"2004","unstructured":"Ho, C. Y. et al. Fenofibrate-induced acute cholestatic hepatitis. J. Chin. Med. Assoc. 67, 245\u2013247 (2004).","journal-title":"J. Chin. Med. Assoc."},{"key":"20731_CR39","doi-asserted-by":"publisher","first-page":"28210","DOI":"10.1074\/jbc.272.45.28210","volume":"272","author":"G Martin","year":"1997","unstructured":"Martin, G., Schoonjans, K., Lefebvre, A. M., Staels, B. & Auwerx, J. Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators. J. Biol. Chem. 272, 28210\u201328217. https:\/\/doi.org\/10.1074\/jbc.272.45.28210 (1997).","journal-title":"J. Biol. Chem."},{"key":"20731_CR40","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1172\/JCI118118","volume":"96","author":"N Vu-Dac","year":"1995","unstructured":"Vu-Dac, N. et al. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor. J. Clin. Invest. 96, 741\u2013750. https:\/\/doi.org\/10.1172\/JCI118118 (1995).","journal-title":"J. Clin. Invest."},{"key":"20731_CR41","doi-asserted-by":"publisher","unstructured":"Rakhshandehroo, M. et al. Comprehensive analysis of PPARalpha-dependent regulation of hepatic lipid metabolism by expression profiling. PPAR Res. 2007, 26839. https:\/\/doi.org\/10.1155\/2007\/26839 (2007).","DOI":"10.1155\/2007\/26839"},{"key":"20731_CR42","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molmet.2014.02.002","volume":"3","author":"S Kersten","year":"2014","unstructured":"Kersten, S. Integrated physiology and systems biology of PPARalpha. Mol. Metab. 3, 354\u2013371. https:\/\/doi.org\/10.1016\/j.molmet.2014.02.002 (2014).","journal-title":"Mol. Metab."},{"key":"20731_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1432-1033.1989.tb14991.x","volume":"184","author":"RK Sharma","year":"1989","unstructured":"Sharma, R. K. et al. Differential induction of peroxisomal and microsomal fatty-acid-oxidising enzymes by peroxisome proliferators in rat liver and kidney. Characterisation of a renal cytochrome P-450 and implications for peroxisome proliferation. Eur. J. Biochem. 184, 69\u201378. https:\/\/doi.org\/10.1111\/j.1432-1033.1989.tb14991.x (1989).","journal-title":"Eur. J. Biochem."},{"key":"20731_CR44","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.3390\/ijms25053038","volume":"25","author":"A Wronska","year":"2024","unstructured":"Wronska, A., Kiezun, J. & Kmiec, Z. High-dose fenofibrate stimulates multiple cellular stress pathways in the kidney of old rats. Int. J. Mol. Sci. 25, 3038. https:\/\/doi.org\/10.3390\/ijms25053038 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"20731_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/toxsci\/kfaa081","volume":"176","author":"WM Gwinn","year":"2020","unstructured":"Gwinn, W. M. et al. Evaluation of 5-day in vivo rat liver and kidney with high-throughput transcriptomics for estimating benchmark doses of apical outcomes. Toxicol. Sci. 176, 343\u2013354. https:\/\/doi.org\/10.1093\/toxsci\/kfaa081 (2020).","journal-title":"Toxicol. Sci."},{"key":"20731_CR46","doi-asserted-by":"publisher","first-page":"D921","DOI":"10.1093\/nar\/gku955","volume":"43","author":"Y Igarashi","year":"2015","unstructured":"Igarashi, Y. et al. Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res. 43, D921\u2013D927. https:\/\/doi.org\/10.1093\/nar\/gku955 (2015).","journal-title":"Nucleic Acids Res."},{"key":"20731_CR47","doi-asserted-by":"publisher","first-page":"e0191105","DOI":"10.1371\/journal.pone.0191105","volume":"13","author":"D Mav","year":"2018","unstructured":"Mav, D. et al. A hybrid gene selection approach to create the S1500\u2009+\u2009targeted gene sets for use in high-throughput transcriptomics. PLoS One. 13, e0191105. https:\/\/doi.org\/10.1371\/journal.pone.0191105 (2018).","journal-title":"PLoS One"},{"key":"20731_CR48","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/gb-2009-10-3-r25","volume":"10","author":"B Langmead","year":"2009","unstructured":"Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25. https:\/\/doi.org\/10.1186\/gb-2009-10-3-r25 (2009).","journal-title":"Genome Biol."},{"key":"20731_CR49","doi-asserted-by":"publisher","first-page":"7108","DOI":"10.3390\/ijms25137108","volume":"25","author":"VR Pannala","year":"2023","unstructured":"Pannala, V. R. et al. Correction: Pannala et al. High-throughput transcriptomics differentiates toxic versus non-toxic chemical exposures using a rat liver model. Int. J. Mol. Sci. 25, 7108.\u00a0https:\/\/doi.org\/10.3390\/ijms25137108 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"20731_CR50","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"20731_CR51","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"20731_CR52","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"20731_CR53","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1186\/s12859-017-1866-7","volume":"18","author":"C Yu","year":"2017","unstructured":"Yu, C. et al. A strategy for evaluating pathway analysis methods. BMC Bioinform. 18, 453. https:\/\/doi.org\/10.1186\/s12859-017-1866-7 (2017).","journal-title":"BMC Bioinform."},{"key":"20731_CR54","doi-asserted-by":"publisher","first-page":"601511","DOI":"10.3389\/fphar.2021.601511","volume":"12","author":"P Schyman","year":"2021","unstructured":"Schyman, P., Xu, Z., Desai, V. & Wallqvist, A. TOXPANEL: a gene-set analysis tool to assess liver and kidney injuries. Front. Pharmacol. 12, 601511. https:\/\/doi.org\/10.3389\/fphar.2021.601511 (2021).","journal-title":"Front. Pharmacol."},{"key":"20731_CR55","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1016\/j.apsb.2024.03.030","volume":"14","author":"S Fan","year":"2024","unstructured":"Fan, S. et al. Fenofibrate-promoted hepatomegaly and liver regeneration are PPARalpha-dependent and partially related to the YAP pathway. Acta Pharm. Sin B. 14, 2992\u20133008. https:\/\/doi.org\/10.1016\/j.apsb.2024.03.030 (2024).","journal-title":"Acta Pharm. Sin B"},{"key":"20731_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1006\/phrs.1996.0046","volume":"33","author":"K Yamamoto","year":"1996","unstructured":"Yamamoto, K., Fukuda, N., Zhang, L. & Sakai, T. Altered hepatic metabolism of fatty acids in rats fed a hypolipidaemic drug, fenofibrate. Pharmacol. Res. 33, 337\u2013342. https:\/\/doi.org\/10.1006\/phrs.1996.0046 (1996).","journal-title":"Pharmacol. Res."},{"key":"20731_CR57","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/toxsci\/kfab038","volume":"181","author":"WE Glaab","year":"2021","unstructured":"Glaab, W. E. et al. Universal toxicity gene signatures for early identification of drug-induced tissue injuries in rats. Toxicol. Sci. 181, 148\u2013159. https:\/\/doi.org\/10.1093\/toxsci\/kfab038 (2021).","journal-title":"Toxicol. Sci."},{"key":"20731_CR58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/347645a0","volume":"347","author":"I Issemann","year":"1990","unstructured":"Issemann, I. & Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645\u2013650. https:\/\/doi.org\/10.1038\/347645a0 (1990).","journal-title":"Nature"},{"key":"20731_CR59","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.2174\/1381612811319170020","volume":"19","author":"N Katsiki","year":"2013","unstructured":"Katsiki, N. et al. The role of fibrate treatment in dyslipidemia: an overview. Curr. Pharm. Des. 19, 3124\u20133131. https:\/\/doi.org\/10.2174\/1381612811319170020 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"20731_CR60","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1128\/MCB.15.6.3012","volume":"15","author":"SS Lee","year":"1995","unstructured":"Lee, S. S. et al. Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15, 3012\u20133022. https:\/\/doi.org\/10.1128\/MCB.15.6.3012 (1995).","journal-title":"Mol. Cell. Biol."},{"key":"20731_CR61","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1158\/0008-5472.CAN-04-0322","volume":"64","author":"C Cheung","year":"2004","unstructured":"Cheung, C. et al. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64, 3849\u20133854. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-0322 (2004).","journal-title":"Cancer Res."},{"key":"20731_CR62","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12864-018-4834-3","volume":"19","author":"MA de la Rosa Rodriguez","year":"2018","unstructured":"de la Rosa Rodriguez, M. A. et al. The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice. BMC Genom. 19, 443. https:\/\/doi.org\/10.1186\/s12864-018-4834-3 (2018).","journal-title":"BMC Genom."},{"key":"20731_CR63","doi-asserted-by":"publisher","first-page":"F323","DOI":"10.1152\/ajprenal.00596.2015","volume":"312","author":"M Sohn","year":"2017","unstructured":"Sohn, M. et al. Delayed treatment with fenofibrate protects against high-fat diet-induced kidney injury in mice: the possible role of AMPK autophagy. Am. J. Physiol. Ren. Physiol. 312, F323\u2013F334. https:\/\/doi.org\/10.1152\/ajprenal.00596.2015 (2017).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"20731_CR64","doi-asserted-by":"publisher","first-page":"F122","DOI":"10.1152\/ajprenal.00352.2017","volume":"314","author":"R Lakhia","year":"2018","unstructured":"Lakhia, R. et al. PPARalpha agonist fenofibrate enhances fatty acid beta-oxidation and attenuates polycystic kidney and liver disease in mice. Am. J. Physiol. Ren. Physiol. 314, F122\u2013F131. https:\/\/doi.org\/10.1152\/ajprenal.00352.2017 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"20731_CR65","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/ki.2010.530","volume":"79","author":"Y Tanaka","year":"2011","unstructured":"Tanaka, Y. et al. Fenofibrate, a PPARalpha agonist, has renoprotective effects in mice by enhancing renal lipolysis. Kidney Int. 79, 871\u2013882. https:\/\/doi.org\/10.1038\/ki.2010.530 (2011).","journal-title":"Kidney Int."},{"key":"20731_CR66","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1210\/mend.16.5.0833","volume":"16","author":"I Pineda Torra","year":"2002","unstructured":"Pineda Torra, I., Jamshidi, Y., Flavell, D. M., Fruchart, J. C. & Staels, B. Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element. Mol. Endocrinol. 16, 1013\u20131028. https:\/\/doi.org\/10.1210\/mend.16.5.0833 (2002).","journal-title":"Mol. Endocrinol."},{"key":"20731_CR67","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1172\/JCI117717","volume":"95","author":"B Staels","year":"1995","unstructured":"Staels, B. et al. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95, 705\u2013712. https:\/\/doi.org\/10.1172\/JCI117717 (1995).","journal-title":"J. Clin. Invest."},{"key":"20731_CR68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.livres.2023.11.006","volume":"7","author":"P Zou","year":"2023","unstructured":"Zou, P. & Wang, L. Dietary pattern and hepatic lipid metabolism. Liver Res. 7, 275\u2013284. https:\/\/doi.org\/10.1016\/j.livres.2023.11.006 (2023).","journal-title":"Liver Res."},{"key":"20731_CR69","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","volume":"106","author":"LE Lee","year":"2024","unstructured":"Lee, L. E., Doke, T., Mukhi, D. & Susztak, K. The key role of altered tubule cell lipid metabolism in kidney disease development. Kidney Int. 106, 24\u201334. https:\/\/doi.org\/10.1016\/j.kint.2024.02.025 (2024).","journal-title":"Kidney Int."},{"key":"20731_CR70","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat. Rev. Nephrol. 13, 769\u2013781. https:\/\/doi.org\/10.1038\/nrneph.2017.126 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"20731_CR71","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","volume":"20","author":"X Su","year":"2009","unstructured":"Su, X. & Abumrad, N. A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 20, 72\u201377. https:\/\/doi.org\/10.1016\/j.tem.2008.11.001 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"20731_CR72","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/0264-6021:3540189","volume":"354","author":"JF Louet","year":"2001","unstructured":"Louet, J. F. et al. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway. Biochem. J. 354, 189\u2013197. https:\/\/doi.org\/10.1042\/0264-6021:3540189 (2001).","journal-title":"Biochem. J."},{"key":"20731_CR73","doi-asserted-by":"publisher","first-page":"50237","DOI":"10.1074\/jbc.M201208200","volume":"277","author":"J Xu","year":"2002","unstructured":"Xu, J. et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J. Biol. Chem. 277, 50237\u201350244. https:\/\/doi.org\/10.1074\/jbc.M201208200 (2002).","journal-title":"J. Biol. Chem."},{"key":"20731_CR74","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1172\/JCI20468","volume":"114","author":"D Patsouris","year":"2004","unstructured":"Patsouris, D. et al. PPARalpha governs glycerol metabolism. J. Clin. Invest. 114, 94\u2013103. https:\/\/doi.org\/10.1172\/JCI20468 (2004).","journal-title":"J. Clin. Invest."},{"key":"20731_CR75","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1096\/fj.01-0147com","volume":"15","author":"S Kersten","year":"2001","unstructured":"Kersten, S. et al. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J. 15, 1971\u20131978. https:\/\/doi.org\/10.1096\/fj.01-0147com (2001).","journal-title":"FASEB J."},{"key":"20731_CR76","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2131\/jts.45.475","volume":"45","author":"Y Amagase","year":"2020","unstructured":"Amagase, Y., Mizukawa, Y. & Urushidani, T. Peroxisome proliferator-activated receptor alpha agonist-induced histidine decarboxylase gene expression in the rat and mouse liver. J. Toxicol. Sci. 45, 475\u2013492. https:\/\/doi.org\/10.2131\/jts.45.475 (2020).","journal-title":"J. Toxicol. Sci."},{"key":"20731_CR77","doi-asserted-by":"publisher","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","volume":"4","author":"M Rakhshandehroo","year":"2009","unstructured":"Rakhshandehroo, M., Hooiveld, G., Muller, M. & Kersten, S. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One. 4, e6796. https:\/\/doi.org\/10.1371\/journal.pone.0006796 (2009).","journal-title":"PLoS One"},{"key":"20731_CR78","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1124\/mol.53.1.14","volume":"53","author":"CN Palmer","year":"1998","unstructured":"Palmer, C. N., Hsu, M. H., Griffin, K. J., Raucy, J. L. & Johnson, E. F. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol. Pharmacol. 53, 14\u201322 (1998).","journal-title":"Mol. Pharmacol."},{"key":"20731_CR79","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1210\/mend.13.9.0341","volume":"13","author":"P Gervois","year":"1999","unstructured":"Gervois, P. et al. A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity. Mol. Endocrinol. 13, 1535\u20131549. https:\/\/doi.org\/10.1210\/mend.13.9.0341 (1999).","journal-title":"Mol. Endocrinol."},{"key":"20731_CR80","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.dld.2007.10.002","volume":"40","author":"C Fernandez-Miranda","year":"2008","unstructured":"Fernandez-Miranda, C. et al. A pilot trial of Fenofibrate for the treatment of non-alcoholic fatty liver disease. Dig. Liver Dis. 40, 200\u2013205. https:\/\/doi.org\/10.1016\/j.dld.2007.10.002 (2008).","journal-title":"Dig. Liver Dis."},{"key":"20731_CR81","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s10620-012-2118-3","volume":"57","author":"W Nseir","year":"2012","unstructured":"Nseir, W., Mograbi, J. & Ghali, M. Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies. Dig. Dis. Sci. 57, 1773\u20131781. https:\/\/doi.org\/10.1007\/s10620-012-2118-3 (2012).","journal-title":"Dig. Dis. Sci."},{"key":"20731_CR82","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1007\/s10620-017-4812-7","volume":"62","author":"J Ahmad","year":"2017","unstructured":"Ahmad, J. et al. Identification and characterization of fenofibrate-induced liver injury. Dig. Dis. Sci. 62, 3596\u20133604. https:\/\/doi.org\/10.1007\/s10620-017-4812-7 (2017).","journal-title":"Dig. Dis. Sci."},{"key":"20731_CR83","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4103\/jrms.JRMS_772_19","volume":"25","author":"F Emami","year":"2020","unstructured":"Emami, F., Hariri, A., Matinfar, M. & Nematbakhsh, M. Fenofibrate-induced renal dysfunction, yes or no? J. Res. Med. Sci. 25, 39. https:\/\/doi.org\/10.4103\/jrms.JRMS_772_19 (2020).","journal-title":"J. Res. Med. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20731-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:32:46Z","timestamp":1761125566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20731-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20731"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20731-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36842"}}